SCHEMBL12579062

SCHEMBL12579062

CCS(=O)(=O)NC1Cc2c(n(Cc3cccc(F)n3)c3ccc(C#N)cc23)C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH1 P35367 1/20 0.36
▸ HTR6 P50406 1/20 0.36
▸ SCARB1 Q8WTV0 4/20 0.35
▸ PARG Q86W56 3/20 0.35
▸ PIK3R1 P27986 1/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ FNTA P49354 1/20 0.33
▸ FNTB P49356 1/20 0.33
▸ AR P10275 1/20 0.32
▸ RORC P51449 2/20 0.32
▸ HSD11B1 P28845 1/20 0.32
▸ IDH1 O75874 1/20 0.31
▸ TBXA2R P21731 1/20 0.31
▸ PTGDR Q13258 1/20 0.31
▸ PTGDR2 Q9Y5Y4 1/20 0.31
▸ CYP11B1 P15538 1/20 0.30
▸ CYP11B2 P19099 1/20 0.30
▸ NR1H2 P55055 1/20 0.30
▸ CASP3 P42574 1/20 0.30
▸ CASP7 P55210 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12579057 0.94 SCARB1 (0.36) HRH1HTR6SCARB1PARGPIK3R1
SCHEMBL2023139 0.94 SCARB1 (0.36) HRH1HTR6SCARB1PARGPIK3R1
SCHEMBL2023590 0.92 HTR6 (0.36) HRH1HTR6SCARB1PARGPIK3R1
SCHEMBL12579051 0.92 HTR6 (0.36) HRH1HTR6SCARB1PARGPIK3R1
SCHEMBL2026761 0.91 SCARB1 (0.36) HRH1HTR6SCARB1PARGPIK3R1
SCHEMBL12579070 0.91 SCARB1 (0.36) HRH1HTR6SCARB1PARGPIK3R1
SCHEMBL2021312 0.90 SCARB1 (0.40) HRH1HTR6SCARB1PARGPIK3R1
SCHEMBL2025539 0.90 SCARB1 (0.40) HRH1HTR6SCARB1PARGPIK3R1
SCHEMBL2027138 0.90 SCARB1 (0.40) HRH1HTR6SCARB1PARGPIK3R1
SCHEMBL12579055 0.90 SCARB1 (0.40) HRH1HTR6SCARB1PARGPIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968587-B2 Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators ELI LILLY AND COMPANY (US) 2011-06-28 — — US disclosed
US-7968587-B2 Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators ELI LILLY AND COMPANY (US) 2011-06-28 — — US disclosed
US-20100069404-A1 TETRAHYDROCYCLOPENTA[b] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS ELI LILLY AND COMPANY 2010-03-18 — — US disclosed
US-20100069404-A1 TETRAHYDROCYCLOPENTA[b] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS ELI LILLY AND COMPANY 2010-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069404-A1 TETRAHYDROCYCLOPENTA[b] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, NR5A1, MUSK HRH1 1313/4885HTR6 251/4885SCARB1 1045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback